AI Engines For more Details: Perplexity Kagi Labs You
Diagnostic Imaging: Iopamidol is primarily used to enhance the visibility of blood vessels, organs, and tissues during various radiographic procedures. It helps to improve the clarity and quality of images obtained, aiding in the diagnosis of medical conditions.
Contrast Enhancement: When injected intravenously, iopamidol circulates through the bloodstream and accumulates in areas of interest, providing contrast enhancement that allows radiologists to visualize structures more clearly. This is particularly useful in detecting abnormalities such as tumors, lesions, or vascular defects.
Adverse Reactions: Like other iodinated contrast agents, iopamidol can cause adverse reactions in some individuals. Common side effects may include:
Allergic Reactions: Allergic reactions to iopamidol are possible but uncommon. Some individuals may experience mild allergic symptoms such as rash, itching, or swelling. In rare cases, severe allergic reactions such as anaphylaxis may occur, which can be life-threatening and require immediate medical attention.
Renal Effects: Iopamidol, like other iodinated contrast agents, can potentially cause kidney damage, especially in patients with pre-existing renal impairment or other risk factors. This adverse effect is known as contrast-induced nephropathy (CIN) and is characterized by a temporary decrease in kidney function following contrast exposure. Patients with impaired renal function should be closely monitored, and precautions may be taken to minimize the risk of CIN.
Thyroid Effects: Iopamidol contains iodine, which can affect thyroid function. Patients with thyroid disorders or those at risk of iodine-induced thyroid dysfunction should be monitored carefully.
Precautions: Healthcare providers should assess patients for any history of allergies, asthma, kidney disease, or thyroid disorders before administering iopamidol. Special precautions may be necessary for vulnerable populations, such as pregnant or breastfeeding women and pediatric patients.
Contrast Extravasation: In rare cases, iopamidol may extravasate (leak) from the injection site into surrounding tissues, leading to tissue irritation or damage. Prompt recognition and management of extravasation events are essential to minimize potential complications.
Contraindications: Iopamidol is contraindicated in patients with a known hypersensitivity to iodinated contrast agents and in those with severe renal impairment, unless the benefits outweigh the risks.
Rank | Probiotic | Impact |
---|---|---|
species | Lacticaseibacillus paracasei | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
Alzheimer's disease | 0.3 | 0 | 0 |
Antiphospholipid syndrome (APS) | 0.3 | -0.3 | |
Atrial fibrillation | 0.3 | -0.3 | |
Autism | 0.3 | -0.3 | |
Bipolar Disorder | 0.3 | 0.3 | |
Cancer (General) | 0.5 | -0.5 | |
Carcinoma | 0.3 | 0.3 | |
Celiac Disease | 0.3 | -0.3 | |
Chronic Fatigue Syndrome | 0 | 0 | 0 |
Chronic Kidney Disease | 0.3 | -0.3 | |
Crohn's Disease | 0.3 | 0.3 | |
Depression | 0.8 | 0.5 | 0.6 |
Hashimoto's thyroiditis | 0.3 | -0.3 | |
Hidradenitis Suppurativa | 0.3 | 0.3 | |
Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
hypersomnia | 0.3 | -0.3 | |
hypertension (High Blood Pressure | 0.3 | -0.3 | |
Inflammatory Bowel Disease | 0 | 0 | |
Liver Cirrhosis | 0.3 | 0.3 | 0 |
Long COVID | 0.3 | -0.3 | |
Lung Cancer | 0.3 | 0.3 | |
Metabolic Syndrome | 0.3 | 0.3 | 0 |
Mood Disorders | 0.8 | 0.5 | 0.6 |
Multiple Sclerosis | 0.3 | 0.3 | |
Obesity | 0.3 | 0.5 | -0.67 |
Parkinson's Disease | 0.3 | 0.3 | |
Polycystic ovary syndrome | 0.3 | -0.3 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.3 | 0.3 | |
Schizophrenia | 0.3 | 0.3 | |
scoliosis | 0.3 | -0.3 | |
Systemic Lupus Erythematosus | 0.3 | 0.3 | |
Type 1 Diabetes | 0.3 | 0.3 | |
Type 2 Diabetes | 0.3 | 0 | 0 |
Ulcerative colitis | 0 | 0.3 | 0 |
Unhealthy Ageing | 0.3 | 0.3 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]